Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-84194-w
Abstract: CYP3A5 is the primary CYP3A subfamily enzyme expressed in the human kidney and its aberrant expression may contribute to a broad spectrum of renal disorders. Pharmacogenetic studies have reported inconsistent linkages between CYP3A5 expression and… read more here.
Keywords: renal disease; expression; cyp3a5 renal; cyp3a5 expression ... See more keywords